ARCHIVES

Brigham & Women’s Suspends Controversial Morcellation Study As Apparent “Difference of Opinion” with FDA Comes to Light

This article is from The Cancer Letter archive.

Vol. 40 No. 45 | December 5, 2014

Download PDF Visit The Full Archive

Related Articles

House Committee Probes NCI $5.2 Billion Sole-Source Contract With SAIC-Frederick.

November 14, 2008

In Brief: Big Ten Cancer Research Consortium Names Executive Officer

May 30, 2014

ACS Plans To Award 10 New Institutional Grants For Up to $200,000 A Year In Cause And Prevention

November 16, 1979

In Brief: Gritz Heads New Dept. At M.D. Anderson; NCI Grants Manager Leo Buscher honored

July 16, 1993

Fitness Reduces Risk of Death From Lung, Colorectal, Prostate Cancer in Middle-Aged Men

May 31, 2013

Garb’s Questions, Answers About Cancer Program

December 5, 1980